{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:12:24Z","timestamp":1791637944162,"version":"4.3.4"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2003,5]]},"abstract":"<jats:p>\n                    Eplerenone is a highly selective aldosterone blocker, which is under development for the treatment of hypertension and heart failure. To assess its usefulness in older patients with systolic hypertension and widened pulse pressure, we compared the effects of eplerenone with amlodipine, on clinic blood pressure (BP) and pulse pressure and in a subset of the patients, ambulatory BP, vascular compliance, and urinary albumin excretion. The study involved 269 patients \u226550 years of age who were randomly assigned to either eplerenone (50 to 200 mg daily) or amlodipine (2.5 to 10 mg daily) in a double-blind titration to effect design. After 24 weeks of therapy, reductions in clinic systolic BP were similar for both treatments (eplerenone, \u221220.5\u00b11.1 mm Hg; amlodipine, \u221220.1\u00b11.1 mm Hg). Reductions in clinic diastolic BP were modestly larger on amlodipine (\u22126.9\u00b10.7 mm Hg) compared with eplerenone (\u22124.5\u00b10.7 mm Hg) (\n                    <jats:italic>P<\/jats:italic>\n                    =0.014). Pulse pressure was also reduced similarly from baseline by the 2 treatment groups (eplerenone, \u221215.9 mm Hg versus amlodipine, \u221213.4 mm Hg,\n                    <jats:italic>P<\/jats:italic>\n                    =0.07). Changes from baseline in pulse wave velocity after 24 weeks of therapy were statistically similar for eplerenone and amlodipine. In patients with microalbuminuria at baseline (&gt;30 mg albumin\/g creatinine), eplerenone reduced the urinary albumin\/creatinine ratio by 52% compared with a reduction of 10% by amlodipine (\n                    <jats:italic>P<\/jats:italic>\n                    =0.04). Thus, eplerenone was as effective as amlodipine in lowering systolic BP and pulse pressure as well as pulse wave velocity in older patients with widened pulse pressure hypertension. Furthermore, eplerenone reduced microalbuminuria to a greater extent than amlodipine in this older patient group.\n                  <\/jats:p>","DOI":"10.1161\/01.hyp.0000067463.13172.ea","type":"journal-article","created":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T16:28:48Z","timestamp":1051806528000},"page":"1021-1026","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":238,"title":["Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension"],"prefix":"10.1161","volume":"41","author":[{"given":"William B.","family":"White","sequence":"first","affiliation":[{"name":"From the Section of Hypertension and Clinical Pharmacology, University of Connecticut School of Medicine (W.B.W.), Farmington, Conn; the Cardiovascular Division, University of Minnesota (D.D.), Minneapolis; Centre Hospitlier Beauce-Etchemin (R.H.), St-Georges, Quebec, Canada; Pharmacia Research and Development (S.K., B.R., J.K.H.), Skokie, Ill; and SUNY-Downstate Medical Center (M.W.), Brooklyn, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Duprez","sequence":"additional","affiliation":[{"name":"From the Section of Hypertension and Clinical Pharmacology, University of Connecticut School of Medicine (W.B.W.), Farmington, Conn; the Cardiovascular Division, University of Minnesota (D.D.), Minneapolis; Centre Hospitlier Beauce-Etchemin (R.H.), St-Georges, Quebec, Canada; Pharmacia Research and Development (S.K., B.R., J.K.H.), Skokie, Ill; and SUNY-Downstate Medical Center (M.W.), Brooklyn, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"St Hillaire","sequence":"additional","affiliation":[{"name":"From the Section of Hypertension and Clinical Pharmacology, University of Connecticut School of Medicine (W.B.W.), Farmington, Conn; the Cardiovascular Division, University of Minnesota (D.D.), Minneapolis; Centre Hospitlier Beauce-Etchemin (R.H.), St-Georges, Quebec, Canada; Pharmacia Research and Development (S.K., B.R., J.K.H.), Skokie, Ill; and SUNY-Downstate Medical Center (M.W.), Brooklyn, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Krause","sequence":"additional","affiliation":[{"name":"From the Section of Hypertension and Clinical Pharmacology, University of Connecticut School of Medicine (W.B.W.), Farmington, Conn; the Cardiovascular Division, University of Minnesota (D.D.), Minneapolis; Centre Hospitlier Beauce-Etchemin (R.H.), St-Georges, Quebec, Canada; Pharmacia Research and Development (S.K., B.R., J.K.H.), Skokie, Ill; and SUNY-Downstate Medical Center (M.W.), Brooklyn, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Roniker","sequence":"additional","affiliation":[{"name":"From the Section of Hypertension and Clinical Pharmacology, University of Connecticut School of Medicine (W.B.W.), Farmington, Conn; the Cardiovascular Division, University of Minnesota (D.D.), Minneapolis; Centre Hospitlier Beauce-Etchemin (R.H.), St-Georges, Quebec, Canada; Pharmacia Research and Development (S.K., B.R., J.K.H.), Skokie, Ill; and SUNY-Downstate Medical Center (M.W.), Brooklyn, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Kuse-Hamilton","sequence":"additional","affiliation":[{"name":"From the Section of Hypertension and Clinical Pharmacology, University of Connecticut School of Medicine (W.B.W.), Farmington, Conn; the Cardiovascular Division, University of Minnesota (D.D.), Minneapolis; Centre Hospitlier Beauce-Etchemin (R.H.), St-Georges, Quebec, Canada; Pharmacia Research and Development (S.K., B.R., J.K.H.), Skokie, Ill; and SUNY-Downstate Medical Center (M.W.), Brooklyn, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Weber","sequence":"additional","affiliation":[{"name":"From the Section of Hypertension and Clinical Pharmacology, University of Connecticut School of Medicine (W.B.W.), Farmington, Conn; the Cardiovascular Division, University of Minnesota (D.D.), Minneapolis; Centre Hospitlier Beauce-Etchemin (R.H.), St-Georges, Quebec, Canada; Pharmacia Research and Development (S.K., B.R., J.K.H.), Skokie, Ill; and SUNY-Downstate Medical Center (M.W.), Brooklyn, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_1_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1993.00410050036006"},{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440420033005"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1991.03460240051027"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)05381-6"},{"key":"e_1_3_1_5_2","first-page":"S3","volume":"17","year":"1999","unstructured":"Black HR, Kuller LH, O\u2019Rourke MF, Weber MA, Alderman MH, Benetos A, Burnett J, Cohn JN, Franklin SS, Mancia G, Safar M, Zanchetti A. The first report of the systolic and pulse pressure (SYPP) working group. J Hypertens. 1999; 17 (suppl 5): S3\u2013S14.","journal-title":"J Hypertens"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890009011765"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.2.149"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)01519-3"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(01)00516-2"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2001.tb00064.x"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(02)02957-6"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","unstructured":"Flack JM Oparil S Pratt JH Roniker B Garthwaithe S Kleiman JH Yang YH Krause SL Workman D Saunders E. Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. J Am Coll Cardiol. 2003. In press.","DOI":"10.1016\/S0735-1097(03)00054-8"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.26.3.485"},{"key":"e_1_3_1_14_2","first-page":"81","volume":"17","year":"2002","unstructured":"Derhaschnig U, Kittler H, Woisetschlager C, Bur A, Herkner H, Hirschl MM. Microalbuminuria measurement alone or calculation of the albumin\/creatinine ratio for the screening of hypertensive patients. Nephrol Dial Tranplant. 2002; 17: 81\u201385.","journal-title":"Nephrol Dial Tranplant"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","unstructured":"White WB. Advances in ambulatory blood pressure monitoring for the evaluation of antihypertensive therapy in research and practice. In: White WB ed. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. Totowa NJ: Humana Press; 2000: 273\u2013298.","DOI":"10.1007\/978-1-59259-004-9_13"},{"key":"e_1_3_1_16_2","unstructured":"Asmar R. Arterial Stiffness and Pulse Wave Velocity. Clinical Applications. Paris: Elsevier; 1999: 143\u2013159."},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1998.1099"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.83.6.1828192"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01096.2001"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.37.2.801"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.300.6720.297"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.33906"},{"key":"e_1_3_1_23_2","first-page":"34","volume":"23","year":"1994","unstructured":"Hoelscher D, Bakris G. Antihypertensive therapy and progression of diabetic renal disease. J Cardiovasc Pharmacol. 1994; 23 (suppl I): 34\u201338.","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000169075"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4892(01)00022-4"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","unstructured":"Blasi ER Rocha R Blomme EAG Rudolph AE Polly ML McMahon EG. Aldostereone and salt induces renal inflammation and fibrosis in hypertensive rats. Am J Physiol. 2003. In press.","DOI":"10.1046\/j.1523-1755.2003.00929.x"},{"key":"e_1_3_1_27_2","first-page":"1072","volume":"62","year":"1998","unstructured":"Jeunemaitre X, Charru A, Chatellier G, Degoulet P, Julien J, Plouin PF, Corvol P, Menard J. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for the treatment of essential hypertension. Am J Cardiol. 1998; 62: 1072\u20131077.","journal-title":"Am J Cardiol"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000067463.13172.EA","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T12:49:35Z","timestamp":1715518175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000067463.13172.EA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1161\/01.HYP.0000067463.13172.EA"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000067463.13172.ea","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]},"assertion":[{"value":"2003-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-03-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-04-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}